Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis

Published:2018-09-21 Issue:3 Volume:19 Page:286-294
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Tangamornsuksan Wimonchat,Lohitnavy Manupat^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-018-0052-2.pdf

Reference65 articles.

1. Maren TH, Haywood JR, Chapman SK, Zimmerman TJ. The pharmacology of methazolamide in relation to the treatment of glaucoma. Invest Ophthalmol Vis Sci. 1977;16:730–42.

2. PubChem Compound Database [Internet]. National Center for Biotechnology Information. [cited December 21, 2017]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/4100 .

3. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331:1272–85.

4. Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clinical reviews in allergy & immunology. 2018;54:147–76.

5. Ergen EN, Hughey LC. Stevens-Johnson syndrome and toxic epidermal necrolysis. JAMA Dermatol. 2017;153:1344.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenomic landscape and pharmacogenomic implications for HLA region in a Taiwan Han Chinese population;Biomarker Research;2024-05-03

2. Drug hypersensitivity linked to genetic variations of human leukocyte antigen;Therapeutic Drug Monitoring;2024

3. Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions;Journal of Allergy and Clinical Immunology;2023-02

4. Association of HLA-C*01:02 with methazolamide-induced toxic epidermal necrolysis;BMJ Case Reports;2022-12

5. Hypersensitivity reactions to small molecule drugs;Frontiers in Immunology;2022-11-10